NIAID-Funded Researchers Probe Potential TB Weaknesses | NIH: National Institute of Allergy and Infectious Diseases
Aporte a la rutina de la trinchera asistencial donde los conocimientos se funden con las demandas de los pacientes, sus necesidades y las esperanzas de permanecer en la gracia de la SALUD.
Tuesday May 22, 2018
As antibiotic-resistant tuberculosis (TB) evolves and spreads, new and innovative treatments will be needed, ideally ones which work in tandem with existing drugs. In a new paper, a group of NIAID-funded scientists describe an unusually detailed examination of a step in the process by which the TB bacterium builds its cell wall. By disrupting this step, the researchers say, they were able to halt the bacteria’s growth—and were able to show that a potential future drug that acted on this pathway could make the bacteria more vulnerable to existing antibiotics. Learn more on the NIAID Now blog: